Enzo Biochem (ENZ) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Provision for uncollectible accounts receivable: 669K
Today's EPS Names:
SUNB, CULP, KFY, More
Financial Fact:
Provision for uncollectible accounts receivable: 669K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $24.2 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance
- BMO cautious on softlines, bearish on athletic names
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
